Below are the most recent publications written about "Blood Coagulation Factors" by people in Profiles.
-
Emigh B, Kobayashi L, Kopp M, Daley M, Teal L, Haan J, Burlew CC, Nirula R, Moore F, Burruss S, Kaminski S, Dunn J, Carrick M, Schroeppel T, Thurston B, Quick J, Bosarge P, Brown CV. The AAST prospective observational multicenter study of the initial experience with reversal of direct oral anticoagulants in trauma patients. Am J Surg. 2021 08; 222(2):264-269.
-
Rhoney DH, La M, Merz M, Cook A, Owusu KA, Roels C, Blunck J, Shewmaker J, Sangha KS, Farrokh S, Lewin J, Chester KW, Human T, Bledsoe K, Greene K, Levesque M, Rocker JC, Davis G, Neyens R, Lassiter TF, Adriance SM. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage. Neurocrit Care. 2021 08; 35(1):130-138.
-
Larrauri B, Hester CG, Jiang H, Miletic VD, Malbran A, Bork K, Kaplan A, Frank M. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor. Mol Immunol. 2020 03; 119:27-34.
-
Smith MN, Deloney L, Carter C, Weant KA, Eriksson EA. Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study. J Thromb Thrombolysis. 2019 Aug; 48(2):250-255.
-
Sasso R, Rockey DC. Controversies in anticoagulation therapy in patients with cirrhosis. Curr Opin Gastroenterol. 2019 05; 35(3):161-167.
-
O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology. 2019 07; 157(1):34-43.e1.
-
Lim MY, McCarthy T, Chen SL, Rollins-Raval MA, Ma AD. Importance of pharmacokinetic studies in the management of acquired factor X deficiency. Eur J Haematol. 2016 Jan; 96(1):60-4.
-
Connors NJ, Gill J, Nakanishi A, Hoffman RS. Porcine blood and surrogate markers do not prove benefit of aDabi-Fab. Crit Care. 2014 Jun 17; 18(3):435.
-
McGlasson DL, Harroff HH, Sutton J, Dick E, Elston DM. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model. Clin Lab Sci. 2007; 20(2):99-105.
-
de Alarcon P, Benjamin R, Dugdale M, Kessler C, Shopnick R, Smith P, Abshire T, Hambleton J, Matthew P, Ortiz I, Cohen A, Konkle BA, Streiff M, Lee M, Wages D, Corash L. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion. 2005 Aug; 45(8):1362-72.